<DOC>
	<DOCNO>NCT01349387</DOCNO>
	<brief_summary>Main objective : Show treatment metformin patient type 2 diabetes effect alternative splicing insulin receptor . Secondary objective : demonstrate effect ratio A/isoform B isoform discontinuation treatment metformin réversé resumption metformin treatment .</brief_summary>
	<brief_title>Effect Treatment With Metformin Type 2 Diabetes Patients Alternative Genes Splicing</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Type 2 Diabetic patient usually treat metformin ( ≥ 1400 mg/day ) , associate oral antidiabetic treatment . injection treatment Patients major . Patients social security number Patients sign consent participate study Intolerance metformin Patients type 1 . Patients pioglitazone rosiglitazone Renal failure anomaly creatinine clearance ( &lt; 60 mL/min ) . Patients pregnant likely .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>